NCT01502631View on ClinicalTrials.gov

Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI)

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

August 8, 2012

Primary Completion Date

September 21, 2014

Study Completion Date

September 21, 2014

Conditions
Acute Spinal Cord Injury
Interventions
DRUG

SUN13837 injection

SUN13837 injection, injection 1 x daily for 28 doses

DRUG

Placebo

Matching placebo, volume equivalent to injection 1 x daily for 28 doses

Trial Locations (67)

10595

Valhalla

10605

White Plains

11021

Great Neck

15670

A Coruña

19102

Philadelphia

19140

Philadelphia

19355

Malvern

19718

Newark

27157

Winston-Salem

28203

Charlotte

30309

Atlanta

30322

Atlanta

33021

Hollywood

33076

Bordeaux

33523

Bordeaux

34090

Montpellier

34295

Montpellier

40504

Lexington

40536

Lexington

41013

Seville

44109

Cleveland

45409

Dayton

52242

Iowa City

52804

Davenport

53226

Milwaukee

59037

Lille

62608

Berck

64108

Kansas City

65203

Columbia

65212

Columbia

65807

Springfield

66160

Kansas City

67214

Indianapolis

68122

Omaha

68506

Lincoln

80054

Amiens

80113

Englewood

80204

Denver

85724

Tucson

90033

Los Angeles

90242

Downey

95128

San Jose

95817

Sacramento

96813

Honolulu

68198-2035

Omaha

08103

Camden

07103

Newark

07052

West Orange

11794-8122

Stony Brook

B3H3A7

Halifax

L8L2X2

Hamilton

M4G 3V9

Toronto

M4G3V9

Toronto

M5C 1R6

Toronto

S7N 0W8

Saskatoon

625 00

Brno

460 63

Liberec

708 52

Ostrava

150 06

Prague

93-513

Lodz

41-200

Sosnowiec

08035

Barcelona

08316

Barcelona

08916

Barcelona

B15 2WB

Edgbaston

G12 0BQ

Glasgow

TS4 3BW

Middlesbrough

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY